TNBC is a unique immunohistochemical subtype of breast cancer, characterized by minimal expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). This evidence concerns the gene ESR1 and breast cancer.